ZimVie
-
Financial
ZimVie Reports First Quarter 2022 Financial Results
Third party net sales of $234.7 million, inclusive of $120.6 million in dental net sales and $114.1 million in spine…
Read More » -
Financial
ZimVie Reports 2021 Financial Results, Reaffirms 2022 Financial Guidance, and Provides Supplemental Financial Information
2021 third party revenue of $1.009 billion, inclusive of $469 million in dental revenue and $540 million in spine revenueCompleted spine…
Read More » -
Financial
Zimmer Biomet Announces Completion of ZimVie Spinoff
WARSAW, Ind., March 1, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Financial
Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie
– “When-issued” trading of ZimVie common stock expected to begin on February 14, 2022 – Record date for distribution of…
Read More » -
Financial
Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of ZimVie; ZimVie to Host Investor Day on February 7
WARSAW, Ind. and WESTMINSTER, Colo., Jan. 21, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that it has filed…
Read More »